We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
+25.03%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.13B
AUM Growth
-$243M
(-7.2%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-37.82%
Top 10 Holdings %
Top 10 Hldgs %
37.92%
Holding
93
New
20
Increased
16
Reduced
29
Closed
16
Top Buys
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$55.4M |
| 2 |
Kodiak Sciences
KOD
|
+$42.4M |
| 3 |
BrightSpring Health Services
BTSG
|
+$40.1M |
| 4 |
Celldex Therapeutics
CLDX
|
+$33.4M |
| 5 |
Illumina
ILMN
|
+$31.7M |
Top Sells
| 1 |
Xenon Pharmaceuticals
XENE
|
+$74.8M |
| 2 |
Krystal Biotech
KRYS
|
+$67M |
| 3 |
CG Oncology
CGON
|
+$58.5M |
| 4 |
Apogee Therapeutics
APGE
|
+$54.4M |
| 5 |
Danaher
DHR
|
+$42M |
Sector Composition
| 1 | Healthcare | 83.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vera Therapeutics
VERA
$3.05B
| $39.7M | 1.27% |
784,742
+312,003
| +66% | +$11.1M |
|
27
iRhythm Holdings
IRTC
$3.72B
| $38.6M | 1.23% |
217,345
-8,500
| -4% | -$1.51M |
|
28
Transmedics
TMDX
$2.61B
| $38.4M | 1.23% |
315,341
-35,907
| -10% | -$4.51M |
|
29
BioMarin Pharmaceuticals
BMRN
$11.4B
| $35.7M | 1.14% |
601,520
+73,520
| +14% | +$4M |
|
|
30
Illumina
ILMN
$28.3B
| $35.4M | 1.13% |
+269,673
| New | +$31.7M |
|
31
Kymera Therapeutics
KYMR
$9.39B
| $35.3M | 1.13% |
454,259
+177,567
| +64% | +$12M |
|
32
Fulcrum Therapeutics
FULC
$237M
| $34.6M | 1.11% |
3,061,222
+2,841,734
| +1,295% | +$28.9M |
|
33
Penumbra
PEN
$12.5B
| $34.2M | 1.1% |
110,152
-31,376
| -22% | -$8.67M |
|
|
MBX
34
MBX Biosciences
MBX
$2.89B
| $32.1M | 1.03% |
+1,018,600
| New | +$24.7M |
|
|
RAPT
35
DELISTED
RAPT Therapeutics
RAPT
| $31.5M | 1.01% |
+929,694
| New | +$28.9M |
|
36
CareDx
CDNA
$1.54B
| $29.9M | 0.96% |
1,585,220
-597,561
| -27% | -$10M |
|
37
Dyne Therapeutics
DYN
$3.97B
| $28.9M | 0.92% |
1,478,329
-1,252,152
| -46% | -$23.7M |
|
38
enGene Therapeutics
ENGN
$127M
| $28.3M | 0.9% |
3,131,319
+865,000
| +38% | +$6.93M |
|
39
Legend Biotech
LEGN
$4.46B
| $28.2M | 0.9% |
1,298,142
-528,013
| -29% | -$15.1M |
|
40
Maravai LifeSciences
MRVI
$1.04B
| $27.1M | 0.87% |
8,353,287
| – | – |
|
|
41
Danaher
DHR
$142B
| $27.1M | 0.87% |
118,227
-191,112
| -62% | -$42M |
|
42
argenx
ARGX
$54B
| $26.1M | 0.83% |
31,007
-45,084
| -59% | -$38.6M |
|
43
Natera
NTRA
$39.7B
| $25.5M | 0.82% |
+111,500
| New | +$23.3M |
|
|
DRUG
44
Bright Minds Biosciences
DRUG
$745M
| $25.3M | 0.81% |
324,358
+20,673
| +7% | +$1.38M |
|
|
TERN
45
DELISTED
Terns Pharmaceuticals
TERN
| $23.2M | 0.74% |
+575,321
| New | +$13.3M |
|
46
Evolus
EOLS
$392M
| $20.6M | 0.66% |
+3,105,209
| New | +$21M |
|
47
Biogen
BIIB
$29.1B
| $20.4M | 0.65% |
+115,700
| New | +$18.9M |
|
48
OrthoPediatrics
KIDS
$507M
| $19.5M | 0.63% |
1,100,370
-7,400
| -0.7% | -$130K |
|
|
TECX
49
Tectonic Therapeutic
TECX
$613M
| $19.3M | 0.62% |
927,524
+190,657
| +26% | +$3.54M |
|
|
VTYX
50
DELISTED
Ventyx Biosciences
VTYX
| $17.3M | 0.55% |
+1,920,255
| New | +$14.4M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM